Related Experiment Videos

Transmission of macrolide-resistant Mycoplasma pneumoniae within a family

Naoyuki Miyashita1, Yasuhiro Kawai, Hiroto Akaike

  • 1Department of Internal Medicine I, Kawasaki Medical School, 2-1-80 Nakasange, Kita-ku, Okayama, 700-8505, Japan, nao@med.kawasaki-m.ac.jp.

Insights

Macrolide-resistant Mycoplasma pneumoniae can cause family outbreaks, even when azithromycin is used. Early recognition of resistant strains is crucial for preventing spread in close-knit communities.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Genetics

Background:

  • Outbreaks of Mycoplasma pneumoniae are common in closed settings.
  • Data on macrolide-resistant (MR) M. pneumoniae outbreaks are limited.

Observation:

  • A family outbreak involved four sisters infected with MR M. pneumoniae pneumonia.
  • The pathogen was identified via culture and PCR, with a specific genetic mutation (A-to-G at position 2063 in 23S rRNA gene) linked to resistance.
  • Treatment with azithromycin, a first-line agent, was ineffective in three patients.

Findings:

  • All MR M. pneumoniae isolates exhibited high minimum inhibitory concentrations (MICs) for 14- and 15-membered macrolides.
  • Parents tested negative for M. pneumoniae, suggesting limited transmission outside the initial cluster.
  • The outbreak demonstrated the potential for MR M. pneumoniae to spread within families.

Implications:

  • MR M. pneumoniae strains can cause outbreaks in closed environments, similar to macrolide-sensitive strains.
  • Physicians must consider MR M. pneumoniae in suspected outbreaks, especially in populations with close contact.
  • Increased vigilance and diagnostic attention are needed to prevent and manage MR M. pneumoniae infections.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Phylum Tenericutes01:24

Bacterial Phylum Tenericutes

The phylum Tenericutes, which includes the single class Mollicutes, comprises bacteria that lack cell walls. The term "Mollicutes" derives from the Latin word mollis, meaning "soft." These organisms are among the smallest known and are commonly referred to as mycoplasmas due to the prominence of the genus Mycoplasma, which includes well-known human pathogens. Despite their inability to stain gram-positively (a result of their lack of cell walls), mycoplasmas are phylogenetically related to the...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...